We wish to give our heartfelt condolences to the relatives of the deceased and the injured from the Mumbai attacks that started more than 36 hours ago and are still going on. Here at SpicyIP, we hope that at least this incident has been hideous enough for those in a position of responsibility to finally stand up and do more than merely condemn the attacks and ensure that terrorism is something that the common man no longer has to worry […]
On the Mumbai attacks Read More »
In line with their efforts to raise awareness about Intellectual Property Rights in India, the National Institute of Intellectual Property Management (NIIPM) is conducting a series of Training Courses at Nagpur in the month of December., the details of which are mentioned below. These courses run from 9.30 am – 5.30 pm and are open to any interested person 1. A 2 day Training Course on Patents, Designs, Trademarks and GI from 15-16th December. 2. A 1 day Training Course
SpicyIP Event: Training Courses by NIIPM, Nagpur Read More »
As a follow up of the ongoing Confederation of Indian Industry (CII) initiative against Counterfeiting & Piracy, the CII in collaboration with Quality Brand Protection Committee (QBPC) is organizing its 2nd Annual Conference on Counterfeiting & Piracy on 12-13 November 2008 at Hotel Hyatt Regency, Sahar, Near International Airport, Mumbai. The Conference looks to: Serve as a platform to develop close and meaningful Co-operation with the stakeholders. Facilitate international cooperation in fortifying criminal and administrative enforcement of IP through networking.
SpicyIP Event: 2nd Annual International Conference on Counterfeiting & Piracy Read More »
The Government has opposed the new definition of ‘counterfeit drugs’ which The International Medical Products Anti-Counterfeiting Taskforce, backed by the World Health Organisation, has given for being too open-ended and vague. The new definition defines a counterfeit drug as one which “may include products with correct ingredients/components, with wrong ingredients/components, without active ingredients, with incorrect amounts of active ingredients, or with fake packaging”. This applies for counterfeit copies of branded as well as generic drugs. The new definition apparently also
Spicy IP Tidbit: Govt. opposes new definition of Counterfeit Drugs Read More »
After Hari Puttar, it’s the turn of another movie to take the movie-IP spotlight. However, this time the movie is based around a patent. “Flash of Genius“, starring Greg Kinnear, Lauren Graham, Dermot Mulroney and Alan Alda, is the true (and possibly dramatized – I haven’t seen it yet) story about an inventor Robert Kearns, and his battle with the Big 3 of the Auto Industry in America – Ford, Chrysler and GM. The movie opened out earlier this month,
Supporters of Open Access to knowledge will be happy to note that today, Oct 14th, is the first ever “Open Access Day”. SPARC (the Scholarly Publishing and Academic Resources Coalition), Students for FreeCulture, and the Public Library of Science are the founding partners for this initiative to focus on the international movement that is encouraging the unrestricted sharing of publicly funded research results for the further development and advancement of science and society.The basic principle behind Open Access is the
Spicy IP Events: First ever "Open Access Day" Read More »
Readers may recall several posts that have been put up by SpicyIP relating to the controversy that surrounds the eligibility of Software Patents under the new Draft Patent Manual. One major issue of concern was the lack of public consultation during the formation of this text. In response to this, a National Public Meeting on Software Patents is being organized in Bangalore on 4th October with several prominent speakers being invited. More details below: The National Public Meeting on Software
SpicyIP Events: National Public Meeting on Software Patents Read More »
The Patent Office has begun the hearing of Pegasys, India’s first product patent under the new Patent Act, which had been granted to Roche India, the Indian branch of the Swiss Hoffman La Roche, and then subsequently received one of India’s first post-grant opposition in March last year. About Pegasys Pegasys, or Pegylated interferon alfa-2a as it is also known as, is a drug which is used to treat Hepatitis C. The prescribed six-month course of treatment used to cost
Pegasys hearing begins. Read More »
A recent post by our friends at IPKAT on games + DRMs (Digital Rights Management) piqued my curiousity and had me heading towards google for more information on the topic (A few months ago, SpicyIP carried a post on DRMs as well). As it turns out, gamers are reacting very strongly against a move by Electronic Arts to incorporate a new DRM copyright protection system in their new game “Spore” which doesn’t allow more than 3 installations of the game.
DRMs for Games too Read More »
In a recent dismissal (5th Aug) of an application for Special Leave to Appeal, the Supreme Court has made it clear that the mere filing of an application for registration of a Trade Mark does not constitute cause of action in a suit for passing off. The appeal [K. Narayanan and Anr. v. S Murali, Civil Appeal Nos. 4480-4481 of 2002] was filed against the decision of the High Court of Madras on the 18th of April, 2002. The facts in brief
Mere filing does not constitute Cause of Action in Passing off Read More »
